Nattopharma ASA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Nattopharma ASA with three other
pharmaceutical manufacturers in Europe:
Enzymatica AB (publ)
sales of 59.45 million Swedish Kronor [US$7.26 million]
Swedencare AB (publ)
(85.49 million Swedish Kronor [US$10.43 million]
Biotec Pharmacon ASA
(66.69 million Norwegian Kroner [US$8.64 million]
During the year ended December of 2017, sales at
Nattopharma ASA were NOK 66.42 million (US$8.61 million).
increase of 28.1%
versus 2016, when the company's sales were NOK 51.83 million.
This was the fifth consecutive year of sales increases at Nattopharma ASA
(and since 2012, sales have increased a total of 489%).